According to a market report by Lucintel, the future of the global neurology sterile injectable market looks promising with opportunities in the hospital pharmacy, drug store, and e-commerce markets. The global neurology sterile injectable market is expected to grow with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising prevalence of neurological disorders and growing efficacy and specificity of injectable therapies.A more than 150-page report to understand trends, opportunity and forecast in neurology sterile injectable market to 2030 by drug type (opioids, steroids, anesthetics, and others), indication (dystonia, blepharospasm, optical neuralgia, and others), distribution channel (hospital pharmacy, drug stores, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the drug type category, opioid is expected to witness the highest growth over the forecast period.
Within the end use category, hospital pharmacy will remain the largest segment.
Download sample by clicking on neurology sterile injectable market
In terms of regions, North America will remain the largest region over the forecast period due to presence of a large patient base, favorable reimbursement policies, and existence of major pharmaceutical manufacturers in the region.
Merck, F-Hoffmann-La Roche, Novartis, Teva Pharmaceutical Industries, BoehringerIngelheimare the major suppliers in the neurology sterile injectable market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Industrial Battery Market
Integrated Gate-Commutated Thyristors (IGCT) Market
Knee Cartilage Repair Market
Landscape Lighting Market
Left Atrial Appendage Closure Devices Market